<DOC>
	<DOCNO>NCT00246077</DOCNO>
	<brief_summary>This study do see impact Lifeport device quality life child sickle cell get chronic transfusion , child 's perspective .</brief_summary>
	<brief_title>Quality Life Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With Lifeport</brief_title>
	<detailed_description>There paucity research focus specifically quality life ( QoL ) among patient sickle cell . This study aim explore QoL child receive chronic transfusion therapy ( CTT ) use Lifeport device , allow undergo erythrocytapheresis , rather standard transfusion therapy . Erythrocytapheresis less time consume associate less iron overload conventional transfusion therapy ; however , little known implication child 's QoL . This study explore QoL child 's perspective .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>Individuals diagnosis sickle cell disease age 8 &amp; 18 year currently receive chronic transfusion therapy via Lifeport device Individuals utilize Lifeport least 6 month 18 month Individuals receive transfusion previously use conventional transfusion therapy ( simple exchange transfusion ) Individuals permission parent ( applicable ) assent Individuals , opinion study staff , would suffer negative consequence , psychosocial trauma , undue stress result participation</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>chronic transfusion therapy</keyword>
	<keyword>quality life</keyword>
</DOC>